Pharmaceutical

Baudax Bio Announces Date of Reconvened Annual Meeting

Annual Meeting to be reconvened on June 23, 2023MALVERN, Pa., June 06, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX)…

9 months ago

Carmot Therapeutics Appoints Michael Gray as Chief Financial Officer and Chief Operating Officer

Gray brings significant biotech financial and operations experience to Carmot to advance a clinical pipeline of therapies to treat people…

9 months ago

Eloxx Pharmaceuticals Granted Extension by Nasdaq to Regain Compliance with the Market Value of Listed Securities Continued Listing Requirement

Company continuing to prepare for advancement of clinical assets, including ELX-02 pivotal study in Alport Syndrome and ZKN-013 Phase 1…

9 months ago

ABVC BioPharma Announces Collaboration With MerDury BioPharma for New Product Development and Commercialization

FREMONT, CA, June 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (“ABVC” or the “Company”) (NASDAQ: ABVC),…

9 months ago

Enlivex to Present at the 2023 Jefferies Healthcare Conference

Nes-Ziona, Israel, June 06, 2023 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage macrophage reprogramming immunotherapy company, today…

9 months ago

Healthmap Solutions Names Eli Wahesh as Chief Operating Officer

Leadership Expansion Part of Healthmap’s Strategic Growth InitiativeTAMPA, Fla., June 06, 2023 (GLOBE NEWSWIRE) -- Kidney population health management company…

9 months ago

Madrigal Pharmaceuticals Supports International NASH Day on June 8

Company expands support for NASH disease education through patient advocacy partnerships and a new digital campaign for patients with at-risk…

9 months ago

Kronos Bio Names Marc Besman, Ph.D., as Senior Vice President of Regulatory Affairs and Clinical Quality Assurance

Dr. Besman brings more than 25 years of regulatory affairs and drug development experience and a track record of successfully advancing…

9 months ago

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

SEATTLE and VANCOUVER, British Columbia, June 06, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical…

9 months ago

AAVantgarde Closes €61 Million Series A Financing to Advance Two Therapeutic Programs into the Clinic

- Financing led by Atlas Venture and Forbion - Company created, incubated and seed financed by Sofinnova Partners MILAN, Italy, June 06,…

9 months ago